Search

everythinglearnresearchcommunity

for

Search:↓

Experts recommend using PN-HPT™ for skin rejuvenation in various body areas but have less agreement on initial facial treatment cycles.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

TRPV4 channel affects skin health and could be a target for treating skin disorders.

A special receptor in sensory nerve endings helps control how they respond to stretching.

Upadacitinib effectively treats pyoderma gangrenosum.

Aδ-LTMRs have complex synapses with glycine, while Aβ-LTMRs have simpler ones.

Stress hormone CRF causes hair loss and inhibits hair growth in human cells.

Blocking androgen receptors early in life increases estrogen levels and reduces sexual motivation in male rats.

Most antiandrogen treatments effectively reduce acne in hyperandrogenic women, but finasteride is the least effective.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

P-SLN nanoparticles effectively deliver podophyllotoxin to the skin.

The treatment successfully lowered testosterone levels and reduced symptoms.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, and antioxidants may help treat hair loss.

Peptide drugs now target hard-to-reach proteins more effectively and specifically.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Dracorhodin perchlorate helps heal wounds in diabetic rats by reducing inflammation.

Platelet-rich plasma improves bladder function and reduces overactivity in ketamine-induced bladder issues.

Cyproterone acetate can effectively treat idiopathic hirsutism, but ethinyl oestradiol and lynoestrenol may not always reduce hair growth.

Activating cannabinoid receptor 1 reduces certain keratin levels, potentially aiding psoriasis treatment.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Hormonal therapy is becoming a promising treatment for acne.

Finasteride reduces opioid use and withdrawal symptoms in animals.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Medical treatments for benign prostatic hyperplasia mainly relieve symptoms, while surgery is more effective but not always suitable for elderly patients.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Trichohyalin is modified by enzymes to form strong structures in hair cells.